England’s Innovative Medicines Fund: Opportunities & Risks
Executive Summary
England’s Innovative Medicines Fund could make the UK a more attractive launch market following Brexit, but companies must also consider the risks of the fund.
You may also be interested in...
England Launches Innovative Medicines Fund
The new financing mechanism promises faster access to new treatments, but some industry concerns remain unresolved.
Advanced Therapies: Payment Revolution Must Accompany Industrial Revolution In Europe
The advanced therapies sector is undergoing something of an industrial revolution, but access issues for products coming to market remain, says Miguel Forte, CEO of Bone Therapeutics. However, there are opportunities to create a better environment for the sector, including regulatory change and more harmonization of HTA processes.
Latin American Countries To Coordinate Purchase Of Monkeypox Vaccine
Member states of the Pan American Health Organization have approved a resolution to combine purchasing power to buy monkeypox vaccines.